atazanavir


Also found in: Medical, Acronyms, Wikipedia.
Related to atazanavir: Abacavir, Truvada
Translations

atazanavir

n atazanavir m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Boosted LPV, atazanavir (ATV), and DRV have all been investigated as monotherapy, and the use of PI monotherapy as a switch in virologically suppressed individuals has been reviewed in detail (14).
This regimen comprised two nucleoside analog reverse transcriptase inhibitors, tenofovir (TDF) and lamivudine (3TC), and one ritonavir (RTV)-boosted protease inhibitor, atazanavir (ATV/r) (2).
The data from the veterans adds to this evidence, and specifically looks at people living with HIV and at an anti-HIV drug, atazanavir, known to elevate bilirubin.
The study, published in the Journal of the American Heart Association, was conducted on 100,000 participants, with an average of 48 years, including people with and without HIV infections The study specifically looks at people living with HIV and at an anti-HIV drug, atazanavir, known to elevate bilirubin, but did not see an independent effect of atazanavir on cardiovascular risk.
(47) Nephrotoxicity due to protease inhibitors (PIs), mainly indinavir and atazanavir, is related to the formation of urolithiasis and intratubular precipitation, obstructive nephropathy, and acute or chronic interstitial nephritis.
WEDNESDAY, April 25, 2018 (HealthDay News) -- For HIV-infected women and their infants, the risk of adverse birth outcomes is similar with tenofovir, emtricitabine, and ritonavir-boosted lopinavir (TDF-FTC-LPV/r) compared with zidovudine, lamivudine, and ritonavir-boosted lopinavir (ZDV-3TC-LPV/r) or TDF-FTC with ritonavir-boosted atazanavir (ATV/r), according to a study published in the April 26 issue of the New England Journal of Medicine.
The Sao Paulo team (20) does not address lipid changes when the nonantiviral cobicistat boosts darunavir or atazanavir. Data reported so far indicate "lipid disturbances ...
Different studies have shown that DRV/r combination therapy is less expensive than other combination therapies such as ritonavir-boosted lopinavir (LPV/r) [8] and ritonavir-boosted atazanavir (ATV/r) [8] but less cost effective compared to dolutegravir (DTG) [9] and raltegravir (RAL) [10].
All subjects were on antiretroviral regimens based upon either darunavir (Prezista), atazanavir (Reyataz), raltegravir (Isentress), or dolutegravir (Tivicay).